Skip to content

The effect of rose water aromatherapy on reducing labor pain

Comparison effect of rosewater and placebo on reducing labor pain in primiporous women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014110914450N3
Enrollment
111
Registered
2014-12-22
Start date
2012-02-13
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor pain. Spontaneous vertex delivery

Interventions

Intervention 1: Intervention group: In initial study (5-4 cm dilation) labor pain intensity was determined by pain visual analogue scale. Then the client was asked to inhale rosewater in dilatation of
Treatment - Drugs
Placebo
Intervention group: In initial study (5-4 cm dilation) labor pain intensity was determined by pain visual analogue scale. Then the client was asked to inhale rosewater in dilatation of 5-7 and 8-10 cm
Placebo group: In initial study (5-4 cm dilation) labor pain intensity was determined by pain visual analogue scale. Then the client was asked to inhale water (placebo) in dilatation of 5-7 and 8-10 c
Control group: In initial study (5-4 cm dilation) labor pain intensity was determined by pain visual analogue scale. Routine care was conducted by the researcher assistant. Pain intensity was measured

Sponsors

Vice Chancellor for research of Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Nulliparous women; Gestational age of 37 weeks until 42 weeks; Singleton; Cephalic presentation; 4 to 5 cm dilation Exclusion criteria: Using other methods of pain relief during the study; Labor complications after intervention; Patient intolerance

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity Labor pain. Timepoint: before and 30 min after intervention. Method of measurement: visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nasrin Roozbahani

Arak University of Medical Sciences

roozbahani@Gmail.com; roozbahani@arakmu.ac.ir+98 86 3368 4615

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026